The fundamentals matter regardless of medication: Calorie deficit through proper nutrition High protein intake (0.7-1g per pound daily minimum) Resistance training 2-4x weekly Adequate sleep and stress management Sustainable lifestyle changes Medications like retatrutide can be powerful tools, but they work best when combined with the basics
Precise dosing and scheduling are fundamental to getting meaningful results when you combine tesamorelin and retatrutide
In the pivotal SURMOUNT-1 trial, participants without diabetes who took tirzepatide for 72 weeks lost an average of 16% of body weight at the 5 mg dose, 21.4% at the 10 mg dose, and 22.5% at the 15 mg dose, compared to just 2.4% in the placebo group
Over 80% of people in the survey agreed that using a weight care medication made them more aware of what they were eating, and had made lasting changes to their physical activity as a result of being on the medication
But when it reaches the market, here's what to expect based on the current GLP-1 insurance landscape: If Approved for Type 2 Diabetes Most commercial insurance plans will cover it, especially if it demonstrates A1C reduction comparable to or exceeding tirzepatide Prior authorization will likely be required Step therapy (try metformin first, then other agents) is standard Copays with manufacturer savings: potentially $25$50/month If Approved for Obesity/Weight Management Coverage remains highly variable, and many plans still exclude weight management medications Medicare Part D: Congress has been debating coverage of anti-obesity medications, but it remains excluded as of early 2026 Self-insured employers increasingly adding GLP-1 coverage, but it's employer-specific Expect significant prior authorization requirements (BMI thresholds, failed diet attempts) The practical reality: even when retatrutide is approved, many people will face the same insurance barriers that currently exist for Wegovy and Zepbound
Some people achieve their goals without ever reaching the maximum dose
